<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Plasma technology is now being considered as an alternative. Blood is collected from a person who has recovered from COVID-19. Separation of serum and screening is done for virus-neutralising antibodies. Convalescent serum, rich in antibodies for the pathogen, is then administered to a COVID-19 patient, who thus acquires passive immunity (Ivan et al. 
 <xref ref-type="bibr" rid="CR28">2011</xref>; Duan et al. 
 <xref ref-type="bibr" rid="CR18">2020</xref>; Bethany and Mc Cullough 
 <xref ref-type="bibr" rid="CR8">2020</xref>; Paital et al. 
 <xref ref-type="bibr" rid="CR62">2020</xref>; Singhal 
 <xref ref-type="bibr" rid="CR84">2020</xref>).
</p>
